Marvin Edeas Inventions, Patents and Patent Applications - Justia Patents Search
HIV - Important Research
Marvin Edeas (http://patents.justia.com) was recognised by Sidaction for his efforts on HIV. The factors that cause blastogenic plasma in HIV Type 1 cases were revealed by Marvin Edeas in 1997. The latency mechanisms of the HIV virus in patients who are HIV positive, on top of the activation factors, is an area which he spent six years studying at the Antoine Béclère Hospital.
Marvin Edeas - A Globally Recognised Scientist
Numerous firms make use of Marvin Edeas’ expertise. He associates with the Agency for the Evaluation of Research and Higher Education (AERES) and Krakow's National Science Center. Marvin Edeas is co-editor of the Mitochondria Society's magazine and furthermore chairs its yearly congress, as a founder and former Chair.
Visiting Professor at the Cochin Institute - Marvin Edeas
His research and study centres on the effects of oxidative stress and inflammation in chronic diseases. Marvin Edeas holds studies which assess the impact of microbiota metabolites on the mitochondrial activity of nephrology patients. Marvin Edeas has been a professor (visiting) at the Cochin Institute, Paris Descartes University, ever since 2016.
Marvin Edeas’ discoveries have found a very real application. Marvin Edeas prevailed in pinpointing two Nrf-2 modulators isolated from peptides and proteins, which can trigger the antioxidant system of defence. As a result of these patents, a start-up company was launched in order to market the peptide.
In the year 1998, Marvin Edeas gained his doctorate on HIV infections in asymptomatic patients from Antoine Béclère Hospital. Marvin Edeas was employed by the Pulmonary Diseases Department at Armand Trousseau Hospital in the early 1990's. He concentrated his efforts on gastrointestinal disease in Pitié Salpêtrière’s Internal Medicine Department.